Advanced search
Start date
Betweenand

Genomic and functional characterization of putative melanoma-restricted lncRNAs (RMELs)

Grant number: 18/04017-9
Support type:Regular Research Grants
Duration: June 01, 2018 - May 31, 2020
Field of knowledge:Biological Sciences - Biochemistry
Principal Investigator:Enilza Maria Espreafico
Grantee:Enilza Maria Espreafico
Home Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil

Abstract

RMEL genes, first described by our group in 2010, are potential lncRNAs with expression restricted to melanoma. High expression of RMELs 2, 3 and 4 (HCCAT5) is associated with the presence of BRAFV600E, the major driver mutation of tumorigenesis in melanoma and other cancers. Ongoing research in our laboratory demonstrates that RMEL3 is a target of MAPK and PI3K pathways, and the transcript, conversely, appears to take part in a feedback positive looping of these pathways. Knockdown and overexpression approaches indicate that all four lncRNA, subject of this study, in different ways and intensity, act by promoting survival and proliferation of melanoma cells. Transcriptomics, proteomics and bioinformatics integrative analyses show that knockdown of RMELs in melanoma cells influences the expression of major pathways involved in proliferation/survival and therapeutic resistance to BRAF/MEK inhibitors or immunotherapy. RMEL2 (annotated as OVAAL) is overexpressed in a smaller number of melanoma cases and cell lines than the other three RMELs and, although silencing of RMEL2 does not affect proliferation under normal adherent conditions, lead to significant reduction of the anchorage-independent growth, and we present evidence of an association of RMEL2 with therapeutic resistance. RMEL1 shows good correlation with MITF and a program of melanocytic differentiation/survival. RMEL4 appears to correlate with a molecular signature of immunotherapy non-responsive melanoma patients. Encouraged by these results, we propose here to characterize these lncRNAs regarding their structures, isoforms, molecular interactions, subcellular localization, coding capacity, and bi-functionality. Interactions with microRNAs and proteins will be analyzed using Luciferase reporter assay and pulldown assays, respectively. Additionally, we will pursue functional studies using overexpression and knockdown (or CRISPr knockout) approaches for in vitro and in vivo analysis to explore the functions of these lncRNAs and applicability in different biological context and therapeutic settings in mouse models. (AU)

Articles published in Agência FAPESP about the research grant
Study identifies new functions of molecule involved in melanoma 
Articles published in other Midia (1 total):
Study Identifies New Functions of Molecule Involved in Melanoma 

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
DOLCE, LUCIANO G.; SILVA-JUNIOR, RUI M. P.; ASSIS, LEANDRO H. P.; NASCIMENTO, ANDREY F. Z.; ARAUJO, JACKELINE S.; MESCHEDE, INGRID P.; ESPREAFICO, ENILZA M.; DE GIUSEPPE, PRISCILA O.; MURAKAMI, MARIO T. Myosin Va interacts with the exosomal protein spermine synthase. BIOSCIENCE REPORTS, v. 39, n. 3 MAR 29 2019. Web of Science Citations: 1.
CARDOSO, CIBELE; SERAFIM, RODOLFO B.; KAWAKAMI, AKINORI; PEREIRA, CRISTIANO GONCALVES; ROSZIK, JASON; VALENTE, VALERIA; VAZQUEZ, VINICIUS L.; FISHER, DAVID E.; ESPREAFICO, ENILZA M. The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth. PIGMENT CELL & MELANOMA RESEARCH, v. 32, n. 2, p. 303-314, MAR 2019. Web of Science Citations: 0.
ARAUJO, L. F.; SIENA, A. D. D.; PLACA, J. R.; BROTTO, D. B.; BARROS, I. I.; MUYS, B. R.; BIAGI JR, C. A. O.; PERONNI, K. C.; SOUSA, J. F.; MOLFETTA, G. A.; WEST, L. C.; WEST, A. P.; LEOPOLDINO, A. M.; ESPREAFICO, E. M.; SILVA JR, W. A. Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma. SCIENTIFIC REPORTS, v. 8, SEP 21 2018. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.
Distribution map of accesses to this page
Click here to view the access summary to this page.